3D nanomatrix vascular sheet model for high-throughput atherosclerosis drug testing

A groundbreaking 3D, three-layer nanomatrix vascular sheet that possesses multiple features of atherosclerosis has been applied for developing a high-throughput functional assay of drug candidates to treat this disease, University of Alabama at Birmingham researchers report in the journal Biomaterials.

FDA puts BioNTech’s malaria vaccine on clinical hold

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

March 6, 2025

Novel model provides a comprehensive framework for studying viral epidemiology and evolutionary dynamics

Understanding the mutation and evolution of viruses (such as SARS-CoV-2) is crucial for effective public health management and response.

April 12, 2024

Otsuka and Astex’s oral Inaqovi wins European approval for AML – Pharmaceutical Technology

Inaqovi is a fixed-dose combination of 35mg decitabine, a hypomethylating agent, and 100mg cedazuridine, a cytidine deaminase inhibitor. Image Credit: Nemes Laszlo / Shutterstock. The

September 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.